ETF overview
The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) is designed to replicate the overall financial performance of the Solactive Genomics v2 Index. This includes mirroring both the index's price movements and its income generation, prior to the deduction of fund fees and operating expenses.
Fund facts
- Expense ratio
- 0.50%
- Fund assets
- 145.18M USD (all share classes)
- Issuer
- Global X
- Inception date
- Nov 2, 2021
- Number of holdings
- 51
Breakdown
Holdings (51)
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 11.64% |
| 10X GENOMICS INC-CLASS A | TXG | 6.14% |
| TWIST BIOSCIENCE CORP | TWST | 6.05% |
| ILLUMINA INC | ILMN | 5.95% |
| NATERA INC | NTRA | 5.61% |
| GUARDANT HEALTH INC | GH | 5.25% |
| GENSCRIPT BIOTECH CORP | 1548.HK | 3.74% |
| BIO-TECHNE CORP | TECH | 3.67% |
| QIAGEN N.V. | QIA.DE | 3.42% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.40% |
| and 38 more | ||
Similar ETFs
- Global X - Genomics & Biotechnology ETFGNOM · Overlap 97% · Expense ratio 0.50%
- Ark Genomic Revolution Ucits ETF AccumUSDARKG.L · Overlap 41% · Expense ratio 0.75%
- ARK Genomic Revolution ETFARKG · Overlap 42% · Expense ratio 0.75%
- Invesco Biotechnology & Genome ETFPBE · Overlap 32% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
Global X - Genomics & Biotechnology UCITS ETF (GNOG.L)
- Expense ratio
- 0.50%
- Fund assets
- 145.18M USD (all share classes)
- Issuer
- Global X
- Inception date
- Nov 2, 2021
- Number of holdings
- 51
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 11.64% |
| 10X GENOMICS INC-CLASS A | TXG | 6.14% |
| TWIST BIOSCIENCE CORP | TWST | 6.05% |
| ILLUMINA INC | ILMN | 5.95% |
| NATERA INC | NTRA | 5.61% |
| GUARDANT HEALTH INC | GH | 5.25% |
| GENSCRIPT BIOTECH CORP | 1548.HK | 3.74% |
| BIO-TECHNE CORP | TECH | 3.67% |
| QIAGEN N.V. | QIA.DE | 3.42% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.40% |
| and 38 more | ||
The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) is designed to replicate the overall financial performance of the Solactive Genomics v2 Index. This includes mirroring both the index's price movements and its income generation, prior to the deduction of fund fees and operating expenses.
- Global X - Genomics & Biotechnology ETFGNOM · Overlap 97% · Expense ratio 0.50%
- Ark Genomic Revolution Ucits ETF AccumUSDARKG.L · Overlap 41% · Expense ratio 0.75%
- ARK Genomic Revolution ETFARKG · Overlap 42% · Expense ratio 0.75%
- Invesco Biotechnology & Genome ETFPBE · Overlap 32% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free